BAE Systems also came under pressure, falling 24p to 1797p despite its upgrade to 2025 guidance. GSK also surrendered initial ...

GSK (LSE: GSK) posted a 6% rise in second-quarter sales to £8 billion ($10.7 billion), ahead of analyst forecasts. Pre-tax ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Harley-Davidson Shares Jump on Cash Infusion From KKR, Pimco Partnership Harley-Davidson shares jumped after the motorcycle maker said it would pay off debt and accelerate share repurchases with cash ...

GSK's Q2 earnings and revenues top forecasts, with Specialty Medicines and Vaccines driving growth and a raised 2025 outlook boosting shares.

(Sharecast News) - London equities ended Wednesday narrowly mixed as investors weighed stronger-than-expected US economic data against a wave of corporate earnings that failed to inspire. The FTSE 100 ...

The FTSE 100 index closed up just 0.62 of a point at 9,136.94. The FTSE 250 closed 16.49 points lower, 0.1%, at 21,776.58, and the AIM All-Share closed down 3.03 points, 0.4%, at 762.72.

The biggest fallers on the FTSE 100 were Taylor Wimpey, down 6.7p at 100.45p, ConvaTec, down 13.40p at 231.0p, HSBC, down ...

GSK now expects turnover growth to be toward the top end of 3% to 5% and core earnings per share growth to be closer to 8% at ...

GSK tops Q2 estimates with growth in vaccines and specialty drugs, raises 2025 forecast amid progress in major late-stage ...

British pharmaceutical group GlaxoSmithKline said Wednesday that its annual performance should be better than expected, ...

The dollar fell against a basket of currencies after reaching a one-month high Tuesday. Investors await the Federal Reserve's policy decision while focus is also on U.S. second-quarter economic growth ...